About CD Diagnostics
CD Diagnostics is a company based in Claymont (United States) founded in 2008 was acquired by Zimmer Biomet in August 2016. CD Diagnostics has raised $6.61 million across 4 funding rounds from investors including Delaware.gov, Zimmer Biomet and Ben Franklin Technology Partners. The company has 56 employees as of December 31, 2022. CD Diagnostics operates in a competitive market with competitors including Emovi, Kumudha Health Tech, Myoton, Osteolabs and Osteosys, among others.
- Headquarter Claymont, United States
- Employees 56 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cd Diagnostics, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$6.61 M (USD)
in 4 rounds
-
Latest Funding Round
$500 K (USD), Grant
May 07, 2014
-
Investors
Delaware.gov
& 4 more
-
Employee Count
56
as on Dec 31, 2022
-
Acquired by
Zimmer Biomet
(Aug 15, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CD Diagnostics
CD Diagnostics has successfully raised a total of $6.61M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $500 thousand completed in May 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CD Diagnostics
CD Diagnostics has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Delaware.gov, Zimmer Biomet and Ben Franklin Technology Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private investments are made in early and later-stage businesses.
|
Locked | Locked | Locked | |
|
Investment and support are provided for Pennsylvania's tech-based companies.
|
Locked | Locked | Locked | |
|
Healthtech startups are funded by BioStar Capital's venture capital efforts.
|
Locked | Locked | Locked |
Investor details for CD Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CD Diagnostics
Investment portfolio details for CD Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CD Diagnostics
Detailed financials for CD Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cd Diagnostics Comparisons
Peer comparison for CD Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CD Diagnostics
CD Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Emovi, Kumudha Health Tech, Myoton, Osteolabs and Osteosys, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of a knee assessment device
|
|
| Locked | Locked | Locked |
Provider of a diagnostic device for spinal deformities
|
|
| Locked | Locked | Locked |
Develops non-invasive diagnostic devices for monitoring muscle health.
|
|
| Locked | Locked | Locked |
Diagnostic tests for osteoporosis are provided via urine-based biomarkers.
|
|
| Locked | Locked | Locked |
Bone mineral densitometer instruments are developed and marketed globally.
|
Detailed competitors of CD Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cd Diagnostics
Complete news archive for CD Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CD Diagnostics
CD Diagnostics was founded in 2008 and raised its 1st funding round 3 years after it was founded.
CD Diagnostics is headquartered in Claymont, United States. It is registered at Claymont, Delaware, United States.
CD Diagnostics is a funded company, having raised a total of $6.61M across 4 funding rounds to date.
As of Dec 31, 2022, the latest employee count at CD Diagnostics is 56.
CD Diagnostics provides a range of biomarker assays testing synovial fluid for orthopedic disorders through its subsidiary Citrano Lab. The company offers the proprietary Synovasure PJI and NSA test (for alpha defensin, C-reactive protein hemoglobin) and the Synovasure Metal Ion test (cobalt and nickel). In addition, a suite of traditional orthopedic diagnostic tests are also offered.
CD Diagnostics's top competitors include Emovi, Osteolabs and MuscleSound.
CD Diagnostics has 5 investors. Key investors include Delaware.gov, Zimmer Biomet, Ben Franklin Technology Partners, Vital Venture Capital, and BioStar Capital.